Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Adelstein

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid CancerRemco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 21, 2016
Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial DesignMatthew C Ward, Richard Blake Ross, Shlomo A Koyfman, et al.
The Laryngoscope|June 27, 2022
Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal CancerMaxwell Y Lee, Mario Belfiglio, Johnathan Zeng, et al.
Oral Oncology|February 12, 2020
Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancerJoycelin F Canavan, Bridgett A Harr, Joanna W Bodmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junctionMichael J McNamara, David J Adelstein, Joanna W Bodmann, et al.
The Laryngoscope|November 14, 2019
Tumor Volume Useful Beyond Classic Criteria in Selecting Larynx Cancers For Preservation TherapyJonathan M Sharrett, Matthew C Ward, Eric Murray, et al.
Journal of the National Cancer Institute|November 11, 2015
Prospective Clinical Study of Precision Oncology in Solid TumorsDavendra P S Sohal, Brian I Rini, Alok A Khorana, et al.
Practical Radiation Oncology|April 22, 2017
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice GuidelineDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
The Laryngoscope|November 1, 2017
A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancerRichard Blake Ross, Shlomo A Koyfman, Chandana A Reddy, et al.
Head & Neck|July 8, 2022
Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomyMaxwell Y Lee, Jonathan Lee, Sarah Stock, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid CancerRemco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 21, 2016
Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial DesignMatthew C Ward, Richard Blake Ross, Shlomo A Koyfman, et al.
The Laryngoscope|June 27, 2022
Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal CancerMaxwell Y Lee, Mario Belfiglio, Johnathan Zeng, et al.
Oral Oncology|February 12, 2020
Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancerJoycelin F Canavan, Bridgett A Harr, Joanna W Bodmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junctionMichael J McNamara, David J Adelstein, Joanna W Bodmann, et al.
The Laryngoscope|November 14, 2019
Tumor Volume Useful Beyond Classic Criteria in Selecting Larynx Cancers For Preservation TherapyJonathan M Sharrett, Matthew C Ward, Eric Murray, et al.
Journal of the National Cancer Institute|November 11, 2015
Prospective Clinical Study of Precision Oncology in Solid TumorsDavendra P S Sohal, Brian I Rini, Alok A Khorana, et al.
Practical Radiation Oncology|April 22, 2017
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice GuidelineDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
The Laryngoscope|November 1, 2017
A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancerRichard Blake Ross, Shlomo A Koyfman, Chandana A Reddy, et al.
Head & Neck|July 8, 2022
Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomyMaxwell Y Lee, Jonathan Lee, Sarah Stock, et al.
Pageof 11